The connected platform for regenerative medicine.
Biologic science · intelligent devices · clinical evidence · future analytics — engineered as one integrated platform.
4th State Medical is building the infrastructure to connect regenerative biology, medical devices, physician collaboration, and structured evidence into a single disciplined ecosystem.
Biology. Devices.
Data. Evidence.
Regenerative medicine is advancing rapidly, but many technologies remain fragmented. Biologics, delivery systems, clinical protocols, patient outcomes, and research data often exist independently. 4th State Medical is building the infrastructure to connect them.
Secretome science, extracellular signaling, growth factors, and cytokine research.
Connected, traceable device architecture designed for clinical workflow integration.
Structured protocols, outcomes measurement, and disciplined study design.
Consumable identity, session logging, and future analytics under a governed model.
More than a product. A connected regenerative ecosystem.
The platform is being developed to support greater consistency, traceability, clinical learning, and scalability across the regenerative medicine field.
- Stage 01BioSignal SciencesSignaling research & product science
- Stage 02Regenerative Product DevelopmentCharacterization & manufacturing controls
- Stage 034th State Medical DevicesConnected delivery architecture
- Stage 04Clinical Protocol DevelopmentReproducible, evidence-driven design
- Stage 05Physician & Research CollaborationInvestigator networks & study partners
- Stage 06Outcomes & Evidence GenerationStructured measurement & reporting
- Stage 07Future AI & AnalyticsGoverned learning across the platform
Built on decades of regenerative science.
The scientific foundation of 4th State Medical includes the work and experience of internationally recognized regenerative medicine researchers, including Dr. Jonathan Lakey.
Engineering the next generation of regenerative delivery.
A future medical device platform designed to support use consistency, device traceability, consumable authentication, usage logging, workflow integration, and structured evidence generation — subject to development, testing, and regulatory review.
Science should be accessible, organized, and continuously updated.
A central resource for scientific publications, peer-reviewed research, white papers, presentations, posters, videos, patents, clinical collaborations, and future study results.
- Publications
- 07
- Categories
- 11
- Featured
- 02
- Updated
- Q4 2025
Building responsibly through evidence and regulatory progress.
4th State Medical intends to pursue the regulatory pathways appropriate to each product, intended use, and market. Regulatory status, availability, and permitted claims will vary by product and jurisdiction.
- 01Research & Product Development
- 02Engineering & Design Controls
- 03Bench & Performance Testing
- 04Preclinical Evaluation
- 05Clinical & Research Collaboration
- 06Regulatory Submission
- 07510(k) / De Novo Pathway
- 08Commercial Medical Expansion
Help build the future of regenerative medicine.
4th State Medical is actively expanding its scientific, clinical, industrial, and strategic collaboration network.
Backing the infrastructure layer of regenerative medicine.
4th State Medical is building a category-defining platform at the convergence of biologic science, connected devices, and clinical evidence. Qualified investors can access the secure portal for the investment thesis, pipeline, IP position, regulatory strategy, and financial model.
The future of regenerative medicine will be measured, connected, and evidence-driven.
4th State Medical was created to help move regenerative innovation from isolated products toward an integrated platform built around responsible science, intelligent technology, clinical collaboration, and measurable progress.
"Products, technologies, and applications described as being under development may not be cleared, approved, or available for commercial use. Regulatory status and permitted uses vary by product and jurisdiction."